TKTX
Transkaryotic Therapies Inc
Biotechnology company developing enzyme replacement therapies for rare diseases, including Replagal for Fabry disease
CUSIP: 893735100HealthcareUS1 holder
Transkaryotic Therapies Inc
Biotechnology company developing enzyme replacement therapies for rare diseases, including Replagal for Fabry disease
No insider transactions reported in the last 3 years. Look across all recorded history →